Cord Blood Natural Killer (NK) Cells in Leukemia/Lymphoma

NCT02280525 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: Lenalidomide
DRUG: Rituximab
DRUG: Fludarabine
DRUG: Cyclophosphamide
PROCEDURE: NK Cells
DRUG: Cytarabine

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]